Effect of SEA0400, a novel inhibitor of sodium‐calcium exchanger, on myocardial ionic currents

Abstract

<jats:p>The effects of 2‐[4‐[(2,5‐difluorophenyl) methoxy]phenoxy]‐5‐ethoxyaniline (SEA0400), a newly synthesized Na<jats:sup>+</jats:sup>‐Ca<jats:sup>2+</jats:sup> exchanger (NCX) inhibitor, on the NCX current and other membrane currents were examined in isolated guinea‐pig ventricular myocytes and compared with those of 2‐[2‐[4‐(4‐nitrobenzyloxy) phenyl]ethyl]isothiourea (KB‐R7943). SEA0400 concentration‐dependently inhibited the NCX current with a 10 fold higher potency than that of KB‐R7943; 1 μ<jats:sc>M</jats:sc> SEA0400 and 10 μ<jats:sc>M</jats:sc> KB‐R7943 inhibited the NCX current by more than 80%. KB‐R7943, at 10 μ<jats:sc>M</jats:sc>, inhibited the sodium current, L‐type calcium current, delayed rectifier potassium current and inwardly rectifying potassium current by more than 50%, but SEA0400 (1 μ<jats:sc>M</jats:sc>) had no significant effect on these currents. These results indicate that SEA0400 is a potent and highly selective inhibitor of NCX, and would be a powerful tool for further studies on the role of NCX in the heart and the therapeutic potential of its inhibition.</jats:p><jats:p><jats:italic>British Journal of Pharmacology</jats:italic> (2002) <jats:bold>135</jats:bold>, 1096–1100; doi:<jats:ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="doi" xlink:href="10.1038/sj.bjp.0704574">10.1038/sj.bjp.0704574</jats:ext-link></jats:p>

Journal

Citations (29)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top